We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

711 hedge funds and large institutions have $17.9B invested in Exact Sciences in 2025 Q4 according to their latest regulatory filings, with 254 funds opening new positions, 152 increasing their positions, 215 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

925% more funds holding in top 10

Funds holding in top 10: 441 (+37)

159% more first-time investments, than exits

New positions opened: 254 | Existing positions closed: 98

84% more capital invested

Capital invested by funds: $9.7B → $17.9B (+$8.18B)

75% more call options, than puts

Call options by funds: $359M | Put options by funds: $205M

25% more funds holding

Funds holding: 569711 (+142)

0.64% less ownership

Funds ownership: 93.65%93.01% (-0.64%)

29% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 215

Holders
711
Holders Change
+142
Holders Change %
+24.96%
% of All Funds
8.63%
Holding in Top 10
41
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+925%
% of All Funds
0.5%
New
254
Increased
152
Reduced
215
Closed
98
Calls
$359M
Puts
$205M
Net Calls
+$154M
Net Calls Change
+$124M
Name Holding Trade Value Shares
Change
Change in
Stake
ORI
351
Oak Ridge Investments
Illinois
$980K -$46.3K -577 -6%
AB
352
Amalgamated Bank
New York
$979K +$5.06K +63 +0.7%
MSRPS
353
Maryland State Retirement & Pension System
Maryland
$978K +$88.3K +1,100 +13%
SI
354
Stephens Inc
Arkansas
$942K -$133K -1,652 -15%
GA
355
Goldstein Advisors
Wisconsin
$934K -$155K -1,927 -17%
EP
356
Essential Partners
California
$932K +$492K +6,126 +201%
KBC Group
357
KBC Group
Belgium
$930K -$351K -4,367 -32%
Holocene Advisors
358
Holocene Advisors
New York
$927K -$218M -2,716,264 -100%
ETC
359
Exchange Traded Concepts
Oklahoma
$919K -$476K -5,932 -40%
NAM
360
NorthCrest Asset Manangement
Minnesota
$918K +$347K +4,327 +92%
SLAM
361
Swiss Life Asset Management
$917K +$40.6K +506 +6%
KAS
362
Kestra Advisory Services
Texas
$895K -$677K -8,435 -49%
Prudential Financial
363
Prudential Financial
New Jersey
$894K -$3.79M -47,146 -84%
ACM
364
Advisors Capital Management
New Jersey
$882K -$38.1K -474 -5%
PCTC
365
Perkins Coie Trust Company
Washington
$878K
EPW
366
Evolve Private Wealth
California
$860K +$680K +8,471 New
MNBTD
367
Moody National Bank Trust Division
Texas
$850K -$357K -4,441 -35%
Brown Advisory
368
Brown Advisory
Maryland
$818K -$484K -6,023 -43%
Envestnet Portfolio Solutions
369
Envestnet Portfolio Solutions
Illinois
$813K -$354K -4,411 -36%
AA
370
AlphaCentric Advisors
Puerto Rico
$802K +$634K +7,901 New
AF
371
Allworth Financial
California
$782K +$30.1K +375 +5%
CPIG
372
Chicago Partners Investment Group
Illinois
$774K -$424K -5,283 -41%
CIS
373
Custom Index Systems
New York
$773K +$611K +7,614 New
PAG
374
Private Advisor Group
New Jersey
$762K +$6.99K +87 +1%
STA
375
Summit Trail Advisors
New York
$757K -$34.5K -430 -5%

EXAS Hedge Fund Activity: Q4 2025 in Review

711 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2025, worth a combined $17.9B — up 84% from $9.7B a quarter earlier.

Buyers outnumbered sellers: 254 funds opened new EXAS positions and 98 closed out — a net gain of 156 holders — while 152 added to existing stakes and 215 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $614M. The largest seller was Fidelity Investments, cutting an estimated $1.41B.

  • 711 institutional investors held Exact Sciences (EXAS) as of Q4 2025, up from 569 in Q3 2025.
  • Funds reported $17.9B of Exact Sciences stock for Q4 2025, up 84% quarter-over-quarter.
  • 254 funds opened new Exact Sciences positions in Q4 2025 and 98 closed out, a net change of +156 holders.
  • The largest Exact Sciences buyer in Q4 2025 was HBK Investments, an estimated $614M added.
  • The largest Exact Sciences seller in Q4 2025 was Fidelity Investments, an estimated $1.41B sold.

Based on aggregated 13F filings for Q4 2025.